Sight Sciences, Inc. (SGHT)
8.44
+0.02
(+0.24%)
USD |
NASDAQ |
Sep 03, 13:27
Sight Sciences Max Drawdown (5Y) : 96.70% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 96.70% |
| July 31, 2026 | 96.70% |
| June 30, 2026 | 96.70% |
| May 31, 2026 | 96.70% |
| April 30, 2026 | 96.70% |
| March 31, 2026 | 96.70% |
| February 28, 2026 | 96.70% |
| Date | Value |
|---|---|
| January 31, 2026 | 96.70% |
| December 31, 2025 | 96.70% |
| November 30, 2025 | 96.70% |
| October 31, 2025 | 96.70% |
| September 30, 2025 | 96.70% |
| August 31, 2025 | 96.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Integra LifeSciences Holdings Corp. | 88.39% |
| Abbott Laboratories | 39.63% |
| AngioDynamics, Inc. | 82.98% |
| Alphatec Holdings, Inc. | 73.51% |
| AtriCure, Inc. | 77.21% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.86 |
| Beta (5Y) | 2.504 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.79% |
| Historical Sharpe Ratio (5Y) | -0.2598 |
| Historical Sortino (5Y) | -0.5914 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.30% |